Literature DB >> 35170983

The Brief Case: Corynebacterium amycolatum in a Relapsing Urinary Tract Infection of a Feline Patient.

Artem S Rogovskyy1,2, Lindsey K Bailey1, John C Blazier3, James J Cai4,5, Melanie Landis6, Jonathan A Lidbury7, Elena Pavlova7, Jing Wu2.   

Abstract

Entities:  

Keywords:  C. amycolatum; Corynebacterium; UTI; antibiotic resistance; cat

Mesh：

Substances：

Year:  2022        PMID： 35170983      PMCID： PMC8849217          DOI： 10.1128/JCM.00453-21

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   11.677


× No keyword cloud information.
  5 in total

1.  rpoB gene sequencing for identification of Corynebacterium species.

Authors:  Atieh Khamis; Didier Raoult; Bernard La Scola
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

2.  Practical Utility and Accuracy of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Corynebacterium Species and Other Medically Relevant Coryneform-Like Bacteria.

Authors:  Nuntra Suwantarat; Chelsea Weik; Mark Romagnoli; Brandon C Ellis; Nicole Kwiatkowski; Karen C Carroll
Journal:  Am J Clin Pathol       Date:  2016-01       Impact factor: 2.493

3.  Identification of clinical coryneform bacterial isolates: comparison of biochemical methods and sequence analysis of 16S rRNA and rpoB genes.

Authors:  Elisabeth E Adderson; Jan W Boudreaux; Jessica R Cummings; Stanley Pounds; Deborah A Wilson; Gary W Procop; Randall T Hayden
Journal:  J Clin Microbiol       Date:  2007-12-26       Impact factor: 5.948

Review 4.  The genus corynebacterium and other medically relevant coryneform-like bacteria.

Authors:  Kathryn Bernard
Journal:  J Clin Microbiol       Date:  2012-07-25       Impact factor: 5.948

5.  Broad-range bacterial detection and the analysis of unexplained death and critical illness.

Authors:  Simo Nikkari; Fred A Lopez; Paul W Lepp; Paul R Cieslak; Stephen Ladd-Wilson; Douglas Passaro; Richard Danila; David A Relman
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.